Affordable medicines facility for malaria: reasonable or rash?

The Lancet

Volumn 375, Issue 9709, 2010, Pages 121-

  Kamal Yanni, Mohga ^a  

^a Oxfam ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ;

CHILD CARE; CHILDHOOD MORTALITY; DIAGNOSTIC ACCURACY; FUNDING; HEALTH PROGRAM; HUMAN; LETTER; MALARIA; MALARIA CONTROL; PNEUMONIA; PRIORITY JOURNAL;

EID: 73449108440     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60048-7     Document Type: Letter

References (5)

1. Talisuna A., Grewal P., Rwakimari J.B., et al. Cost is killing patients: subsidising effective antimalarials. Lancet 374 (2009) 1224-1226
2. WHO, and UNICEF. Pneumonia: the forgotten killer of children. http://www.unicef.org/publications/index_35626.html (accessed Dec 14, 2009).
3. Yates R. Universal health care and the removal of user fees. Lancet 373: 2078-81.
4. Global Fund to Fight AIDS, and Tuberculosis and Malaria. Fighting malaria in Ethiopia: Ethiopia has halved malaria deaths in just three years. http://www.theglobalfund.org/en/savinglives/ethiopia/ma1/ (accessed Oct 15, 2009).
5. WHO. Malaria deaths decline by 66% in Zambia. http://www.who.int/mediacentre/news/releases/2009/malaria_deaths_zambia_20090423/en/index.html (accessed Oct 15, 2009).